CareLit · DOI-Nachweis · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Contextual factors of implementing APOL1 genetic testing into living kidney donor clinical evaluation
DOI 10.1007/s00103-025-04068-8
Bibliografische Angaben
Nachweis in CareLit
Autor:innenMerle, J.-L.; Kuo, M.-C.; Gacki-Smith, J.; Agrawal, A.; Friedewald, J.; Gordon, E.-J.; Smith, J.-D.
ZeitschriftBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Ausgabe7/2025
Jahrgang / SeitenJg. 68 · S. 758 bis 768
Kernaussage aus der Literatur
Abstract-Vorschau
Living donor kidney transplantation (LDKT) is the preferred treatment for patients with end-stage kidney disease, offering longer graft survival and improved quality of life. However, LDKT poses risks to living donors. Black living donors face disproportionately higher risks of postdonation kidney disease than White counterparts, necessitating deeper understanding of the factors contributing to this disparity. This…
Zitieren
Zitierempfehlung
Merle, J.-L.; Kuo, M.-C.; Gacki-Smith, J.; Agrawal, A.; Friedewald, J.; Gordon, E.-J.; Smith, J.-D (2025) Contextual factors of implementing APOL1 genetic testing into living kidney donor clinical evaluation. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 68 (7), 758 bis 768. https://doi.org/10.1007/s00103-025-04068-8
Mit CareLit weiterarbeiten